Clinical Trials
8 trialsNCT02549638 2025-10-14
Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma
Mayo Clinic
Terminated
NCT04106167 2023-09-21
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
Fate Therapeutics
Terminated
NCT04688749 2023-07-25
DermaSense
Aristotle University Of Thessaloniki
Terminated
NCT00011492 2020-11-27
Patient Evaluation for Head and Neck Surgery Branch Studies
National Institutes of Health Clinical Center (CC)
Terminated
NCT03321903 2019-12-19
EPR Tumor Oximetry With CE India Ink
Dartmouth-Hitchcock Medical Center
Terminated
NCT00507702 2019-04-18
Identification of Key Blood Molecular Markers for Immunotherapy
Stanford University
Terminated
NCT01142869 2017-05-08
An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
Merck KGaA, Darmstadt, Germany
Terminated
NCT01884129 2015-12-10
CTCHNSCC01
Chang Gung Memorial Hospital
Terminated